14.27
0.63%
-0.09
After Hours:
14.26
-0.010
-0.07%
Abrdn Life Sciences Investors stock is traded at $14.27, with a volume of 108.67K.
It is down -0.63% in the last 24 hours and up +5.94% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
See More
Previous Close:
$14.36
Open:
$14.42
24h Volume:
108.67K
Relative Volume:
0.97
Market Cap:
$400.44M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.78%
1M Performance:
+5.94%
6M Performance:
-4.29%
1Y Performance:
+2.37%
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
14.27 | 400.44M | 0 | 0 | 0 | 0.00 |
DNP
Dnp Select Income Fund Inc
|
9.43 | 3.49B | 0 | 0 | 0 | 0.00 |
UTG
Reaves Utility Income Fund
|
33.46 | 2.94B | 0 | 0 | 0 | 0.00 |
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
15.48 | 2.44B | 0 | 0 | 0 | 0.00 |
UTF
Cohen Steers Infrastructure Fund Inc
|
24.39 | 2.35B | 0 | 0 | 0 | 0.00 |
ADX
Adams Diversified Equity Fund
|
20.65 | 2.31B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
Absolute Investment Advisers LLC Invests $5.24 Million in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Insider Selling: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells 1,846 Shares of Stock - MarketBeat
Absolute Investment Advisers LLC Acquires New Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
abrdn plc Increases Stock Position in Omega Healthcare Investors, Inc. (NYSE:OHI) - MarketBeat
Abrdn life sciences investors sees $83,012 in stock sales by major owners - MSN
Saba Capital Management, L.P. Reduces Holdings in abrdn Life Sci - GuruFocus.com
Abrdn life sciences investors sees $83,012 in stock sales by major owners By Investing.com - Investing.com
abrdn plc Cuts Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Shares Acquired by Janney Montgomery Scott LLC - Defense World
Abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update - MarketBeat
Saba Capital Management sells $525k in abrdn Life Sciences stock - MSN
Insider Selling: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells 11,674 Shares of Stock - MarketBeat
Saba Capital Management, L.P. Reduces Stake in abrdn Life Sciences Investors - GuruFocus.com
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 15,143 Shares - MarketBeat
Janney Montgomery Scott LLC Lowers Holdings in Abrdn Healthcare Investors (NYSE:HQH) - Defense World
Short Interest in Harmonic Drive Systems Inc. (OTCMKTS:HSYDF) Rises By 23.1% - Defense World
Aena S.M.E., S.A. (OTCMKTS:ANNSF) Short Interest Update - Defense World
Abrdn Life Sciences Investors (NYSE:HQL) Sees Large Drop in Short Interest - Defense World
Kingswood Wealth Advisors LLC Increases Stake in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Sees Large Increase in Short Interest - MarketBeat
Up 10% in a month! Is the abrdn share price set for the biggest comeback since Lazarus? - Motley Fool UK
Saba capital management sells $164,836 in Abrdn Life Sciences Investors shares By Investing.com - Investing.com Canada
Atalanta Therapeutics Closes Oversubscribed $97 Million Series B Financing to Advance Two RNAi Therapies for CNS Diseases to Clinical Trials - BioSpace
Two Areas of Opportunity for 2025 - Stock Investor
abrdn UK Smaller Cos. Trust complies with market rules - MSN
Abrdn Life Sciences Investors (NYSE:HQL) Stake Trimmed by Flagship Harbor Advisors LLC - MarketBeat
Cyndeo Wealth Partners LLC Sells 25,586 Shares of Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
5 Best CEFs This Month For Nearly 10% Yield (January 2025) - Seeking Alpha
Aberdeen Or 'abrdn'Either Way The Coverage Looks A Bit Thin - Seeking Alpha
Abrdn Life Sciences Investors (NYSE:HQL) Short Interest Up 212.4% in December - Defense World
Jane Street Group LLC Sells 27,170 Shares of Luxfer Holdings PLC (NYSE:LXFR) - Defense World
Abrdn Healthcare Investors (NYSE:HQH) Short Interest Update - MarketBeat
abrdn U.S. Closed-End Funds Announce Distribution Payment Details - AccessWire
Abrdn Healthcare Investors (NYSE:HQH) Stock Price Crosses Below 50-Day Moving AverageTime to Sell? - MarketBeat
Private equity drives dealmaking across sectors with $870m+ in disclosed transactions - Alternatives Watch
Don't Miss The Dividend Train, Yields Up To 15% - Seeking Alpha
HQH: Not For Income Investors - Seeking Alpha
Short Interest in Abrdn Healthcare Investors (NYSE:HQH) Grows By 25.3% - MarketBeat
Sanctuary Advisors LLC Has $183,000 Stake in Abrdn Life Sciences Investors (NYSE:HQL) - Defense World
Barclays PLC Purchases 9,328 Shares of EZCORP, Inc. (NASDAQ:EZPW) - Defense World
Barclays PLC Purchases 39,102 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Barclays PLC Purchases 60,954 Shares of Myers Industries, Inc. (NYSE:MYE) - Defense World
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):